ASX:ARX Aroa Biosurgery (ARX) Stock Price, News & Analysis → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free ARX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Aroa Biosurgery alerts: Email Address Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. About Aroa BiosurgeryAroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.Read More Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. ARX Stock News HeadlinesJune 23, 2022 | finance.yahoo.comBreakeven On The Horizon For Aroa Biosurgery Limited (ASX:ARX)June 6, 2022 | apnews.comThe Worldwide Biosurgery Industry is Expected to Reach $20.6 Billion by 2027 - ResearchAndMarkets.comSee More Headlines Receive ARX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aroa Biosurgery and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:ARX CUSIPN/A CIKN/A Webwww.arcexploration.com.au Phone61 8 6117 0452FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,290,000.00 Net Margins-12.58% Pretax MarginN/A Return on Equity-8.33% Return on Assets-4.16% Debt Debt-to-Equity Ratio6.95 Current Ratio7.83 Quick Ratio8.39 Sales & Book Value Annual Sales$65.89 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.37 Book ValueA$0.28 per share Price / BookN/AMiscellaneous Outstanding Shares343,440,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.68 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Brian WardFounder, CEO, MD & Executive DirectorMr. James Agnew BComLLB, CFO & Joint Company SecretaryMr. Scott Sherriff B.A.M.B.A., Chief Operating OfficerDr. Barnaby C.H. May Ph.D.Chief Scientific OfficerMs. Neetha Alex-KumarGeneral CounselMr. Frazer MurrayDirector of Global Marketing & StrategyMs. Yasmin Winchester B.Sc.Vice President of Quality, Regulatory & SustainabilityMs. Tracy Weimar BAMBA, Joint Company SecretaryMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersSteven (Steve) EngleSold 633,225 sharesTotal: $62,056.05 ($0.10/share)Philip McCawBought 326,000 shares on 2/16/2024Total: $187,450.00 ($0.58/share)James (Jim) McLeanBought 50,000 shares on 9/6/2023Total: $37,500.00 ($0.75/share)Catherine MohrSold 210,686 sharesTotal: $185,403.68 ($0.88/share) ARX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Aroa Biosurgery own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aroa Biosurgery investors own include Algonquin Power & Utilities (AQN), Allied Properties Real Estate Investment (AP.UN), Allied Properties Real Estate Investment Trust (AP), American Tower (AMT), Amgen (AMGN), Applied Materials (AMAT), AltaGas (ALA), Alamos Gold (AGI), Agnico Eagle Mines (AEM) and Air Canada (AC). This page (ASX:ARX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aroa Biosurgery Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
